Cancer Prevention Precision Control Institute (CPPCI)

CPPCI’s Mission

Create a transformational translational research Institute within the Center for Discovery & Innovation that connects science to practice with a tripartite mission focused on cancer prevention and control, improving patient outcomes through improved patient-clinician communication leveraging novel digital and social media outreach tools, and community-engaged participatory research methods.

• Leverage opportunities for community engagement in the greater New Jersey area to improve patient outcomes through cross-cutting cancer prevention and control-focused research;
• Increase the ‘precision’ of cancer prevention and control through tailored interventions as opposed to a ‘one size fits all’ approach;
• Employing innovative quantitative, qualitative, and mixed methods research methodology;
• Build a complementary research team at CDI that cross collaborates with the Georgetown Lombardi CPC research team to improve patient outcomes in the New Jersey and District of Columbia catchment areas (and beyond);
• Develop a community advisory board of diverse citizen scientists who represent the communities we serve to advise the CPPCI leadership quarterly on research needs, foci of clinical interest, and broader direction;
• Build a broad and robust extramural funding portfolio, robust extramural funding portfolio; and
• Recruit and retain exceptional, forward-thinking scholars committed to advancing the field of population sciences in cancer prevention and control.

CPPCI’s Team

Affiliate Investigators

Christina Cho, M.D.
Nitin Yerram, M.D.
Antonia Francis Oladipo, M.D.